JP2006508193A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508193A5
JP2006508193A5 JP2005510377A JP2005510377A JP2006508193A5 JP 2006508193 A5 JP2006508193 A5 JP 2006508193A5 JP 2005510377 A JP2005510377 A JP 2005510377A JP 2005510377 A JP2005510377 A JP 2005510377A JP 2006508193 A5 JP2006508193 A5 JP 2006508193A5
Authority
JP
Japan
Prior art keywords
composition
sialidase
binding
seq
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005510377A
Other languages
English (en)
Japanese (ja)
Other versions
JP5348651B2 (ja
JP2006508193A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/037158 external-priority patent/WO2004047735A2/en
Publication of JP2006508193A publication Critical patent/JP2006508193A/ja
Publication of JP2006508193A5 publication Critical patent/JP2006508193A5/ja
Application granted granted Critical
Publication of JP5348651B2 publication Critical patent/JP5348651B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2005510377A 2002-11-22 2003-11-21 広域抗ウイルス治療および予防薬 Expired - Fee Related JP5348651B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42853502P 2002-11-22 2002-11-22
US60/428,535 2002-11-22
US46421703P 2003-04-19 2003-04-19
US60/464,217 2003-04-19
PCT/US2003/037158 WO2004047735A2 (en) 2002-11-22 2003-11-21 Broad spectrum anti-viral therapeutics and prophylaxis

Publications (3)

Publication Number Publication Date
JP2006508193A JP2006508193A (ja) 2006-03-09
JP2006508193A5 true JP2006508193A5 (cg-RX-API-DMAC7.html) 2008-09-11
JP5348651B2 JP5348651B2 (ja) 2013-11-20

Family

ID=32397132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005510377A Expired - Fee Related JP5348651B2 (ja) 2002-11-22 2003-11-21 広域抗ウイルス治療および予防薬

Country Status (8)

Country Link
US (2) US8084036B2 (cg-RX-API-DMAC7.html)
EP (1) EP1567185B1 (cg-RX-API-DMAC7.html)
JP (1) JP5348651B2 (cg-RX-API-DMAC7.html)
KR (2) KR20090087971A (cg-RX-API-DMAC7.html)
CN (2) CN101804200A (cg-RX-API-DMAC7.html)
AU (1) AU2003294401C1 (cg-RX-API-DMAC7.html)
CA (1) CA2506526C (cg-RX-API-DMAC7.html)
WO (1) WO2004047735A2 (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2506526C (en) * 2002-11-22 2017-04-18 Mang Yu Broad spectrum anti-viral therapeutics and prophylaxis
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US8512710B2 (en) 2002-11-22 2013-08-20 Ansun Biopharma, Inc. Class of therapeutic protein based molecules
US8337814B2 (en) * 2005-12-15 2012-12-25 Topical Sinus Therapeutics, Inc. Treatment of active infections, sinusitis, rhinitis, and related neurological disorders and related compositions
CN101404980A (zh) 2006-01-24 2009-04-08 耐百生物制药有限公司 大分子微球的制备技术
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8084443B2 (en) 2007-10-01 2011-12-27 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
MX2009007139A (es) 2006-12-28 2009-10-08 Centocor Ortho Biotech Inc Metodos y vectores para generar inmunoglobulinas no sialiladas.
CA2989778C (en) * 2007-01-19 2020-06-30 Kai Pharmaceuticals, Inc. Method of modifying peptide compositions
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP2772267B1 (en) 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
US8187591B2 (en) * 2007-10-11 2012-05-29 The Regents Of The University Of California Methods of treating coagulopathy
MX2011004840A (es) * 2008-11-07 2011-08-08 Anhydro Biolog Ltd Composiciones de vacuna.
JP2010229122A (ja) * 2009-03-06 2010-10-14 Kumamoto Univ 抗癌剤、医薬、及び癌疾患の検査薬
CN102448438A (zh) * 2009-03-26 2012-05-09 普马特里克斯公司 抗流行性感冒调配物及方法
JP2011037765A (ja) * 2009-08-11 2011-02-24 Kitasato Institute 新規ペプチド、並びにトリプシン阻害剤、抗インフルエンザウイルス剤、及び抗体
GB0916578D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
CN103200938B (zh) 2010-08-30 2018-07-31 普马特里克斯营业公司 干燥粉末配方及用于治疗肺部疾病的方法
WO2012030645A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
BR112013007304B1 (pt) 2010-09-29 2021-12-14 Pulmatrix, Inc. Pós secos de cátion de metal monovalente para inalação
PT3470057T (pt) 2010-09-29 2021-12-03 Pulmatrix Operating Co Inc Pós secos catiónicos compreendendo sais de magnésio
EP3494989B1 (en) 2012-01-26 2025-07-16 Longhorn Vaccines and Diagnostics, LLC Composite antigenic sequences and vaccines
WO2013123521A1 (en) 2012-02-17 2013-08-22 Nexbio, Inc. Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients
CN107596518B (zh) 2012-02-29 2021-04-23 普马特里克斯营业公司 可吸入干粉剂
EP2866792A4 (en) 2012-06-28 2016-08-17 Ansun Biopharma Inc MICROPARTICLE FORMULATIONS FOR DELIVERY TO LOWER AND CENTRAL RESPIRATORY PATHS AND METHOD OF PREPARING THEM
AU2014248455B2 (en) 2013-04-01 2018-12-06 Pulmatrix Operating Company, Inc. Tiotropium dry powders
US10300116B2 (en) 2013-06-10 2019-05-28 Ansun Biopharma, Inc. Treatment for BK polyomavirus infection
WO2015184356A1 (en) 2014-05-30 2015-12-03 Ansun Biopharma, Inc. Treatment of middle east respiratory syndrome coronavirus
WO2016044656A1 (en) 2014-09-17 2016-03-24 Ansun Biopharma, Inc. Treatment of infection by human enterovirus d68
KR101629821B1 (ko) 2015-01-19 2016-06-21 주식회사 엔터플 Url 쿠폰을 이용한 디지털 상품 제공 방법 및 장치
WO2016115616A1 (en) * 2015-01-21 2016-07-28 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Inhibition of cellular proteases as treatment for influenza
EP3294448A4 (en) 2015-05-14 2018-12-12 Longhorn Vaccines and Diagnostics, LLC Rapid methods for the extraction of nucleic acids from biological samples
US20180271997A1 (en) * 2016-05-31 2018-09-27 Tianxin Wang Methods and Reagents to Treat Tumor and Cancer
CN109641038A (zh) 2016-07-01 2019-04-16 小利兰·斯坦福大学理事会 靶向细胞表面编辑的共轭物
US20200085849A1 (en) * 2017-05-18 2020-03-19 Elysium Health, Inc. Methods and compositions for improving sleep
EP3735458A4 (en) 2018-01-03 2022-04-27 Palleon Pharmaceuticals Inc. RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS AND METHODS OF USE THEREOF
GB201814905D0 (en) * 2018-09-13 2018-10-31 Herwald Heiko Treatment
CN114269937B (zh) * 2019-07-03 2026-04-24 帕利昂制药有限公司 重组唾液酸酶及其使用方法
CA3148394A1 (en) * 2019-07-23 2021-01-28 Csts Health Care Inc. Platelet-facilitated delivery of therapeutic compounds
US12485166B2 (en) 2020-02-06 2025-12-02 Longhorn Vaccines And Diagnostics, Llc Vaccines for the treatment and prevention of zoonotic infections
IE20210235A1 (en) 2020-10-20 2023-08-16 Longhorn Vaccines & Diagnostics Llc Immunogenic antigens

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439089A (en) * 1968-03-27 1969-04-15 Merck & Co Inc Medicated hard candy
US5643758A (en) * 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
RU2054180C1 (ru) 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
US5376633A (en) * 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
WO1998031817A2 (en) * 1997-01-14 1998-07-23 Hopital Sainte-Justine Human lysosomal sialidase and therapeutic uses thereof
US6251392B1 (en) * 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent
ES2246093T3 (es) * 1998-10-16 2006-02-01 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Patogenicida molecular que induce una resistencia a la enfermedad en las plantas.
US6855801B1 (en) * 1999-02-02 2005-02-15 Thomas Jefferson University Peptides modulating activities of heparin other glycosaminoglycans or proteoglycans
US6737511B1 (en) * 1999-08-16 2004-05-18 The United States Of America As Represented By The Department Of Health And Human Services Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
US20020025320A1 (en) * 1999-08-20 2002-02-28 Prosper Boyaka Sialidases as mucosal adjuvants
CA2506526C (en) * 2002-11-22 2017-04-18 Mang Yu Broad spectrum anti-viral therapeutics and prophylaxis
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
CN101404980A (zh) * 2006-01-24 2009-04-08 耐百生物制药有限公司 大分子微球的制备技术

Similar Documents

Publication Publication Date Title
JP2006508193A5 (cg-RX-API-DMAC7.html)
EP1716232B1 (en) Acid alpha-glucosidase and fragments thereof
RU2468080C2 (ru) Новый класс терапевтических белковых молекул
CN1729013B (zh) 广谱抗病毒化合物、药物制剂及其用途
US11241486B2 (en) Treatment of Middle East respiratory syndrome coronavirus
JP2008512117A5 (cg-RX-API-DMAC7.html)
JP2005537244A (ja) 療法化合物の粘膜搬送を増進させるための、上皮接合部接着分子の生理機能を調節する組成物および方法
JP2017529326A5 (cg-RX-API-DMAC7.html)
US20260048102A1 (en) Immunomodulatory compositions and methods
JP2009506033A (ja) Ｐｌｙ−ｇｂｓ突然変異ライシン
US20200164049A1 (en) Treatment of human metapneumovirus
US20220233657A1 (en) Treatment of middle east respiratory syndrome coronavirus
JP2023549167A5 (cg-RX-API-DMAC7.html)
TW202517789A (zh) Ｋｌｋ１融合蛋白質的製備方法
HK40092072A (zh) 用於预防和/或治疗covid-19的组合物和方法
HK40111214A (zh) 包含iga蛋白酶截短体的融合蛋白及其用途
HK40111214B (zh) 包含iga蛋白酶截短体的融合蛋白及其用途
WO2014059403A1 (en) Chimeric proteins, compositions and methods for restoring cholinesterase function at neuromuscular synapses
HK40073765A (en) Immunomodulatory compositions and methods
HK1201562B (en) A novel class of therapeutic protein based molecules
HK1080763B (en) Broad spectrum anti-viral compounds, pharmaceutical formulations and the use thereof